1. OP09 Proactive Therapeutic Drug Monitoring is superior to standard treatment during maintenance therapy with infliximab; results from a 52-week multicentre randomised trial of 450 patients; the NOR-DRUM B study. (21st January 2022) Authors: Jørgensen, K K; Syversen, S W; Goll, G L; Bjørlykke, K H; Sandanger, Ø; Sexton, J; Brun, M K; Noraberg, G; Ystrøm, C M; Seeberg, K A; Blomgren, I M; Torp, R; Mørk, C; Kvien, T K; Bolstad, N; Haavardsholm, E A; Jahnsen, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i010 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P614NLRP3 inflammasome as a sensor of metabolic stress in cardiac fibroblasts. (15th July 2014) Authors: Sokolova, M; Vinge, LE; Alfsnes, K; Ohm, IK; Bliksoen, M; Sandanger, Ø; Aukrust, P; Ranheim, T; Yndestad, A Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗